Scholarlink

<p>Sporotrichosis is a globally distributed subcutaneous mycosis caused by fungi belonging to the <i>Sporothrix</i> genus. The limitations of current treatment options for sporotrichosis have driven an urgent search for new antifungal drugs. Diphenyl diselenide (PhSe)₂, a stable organoselenium, has promising activity against <i>Sporothrix</i> spp. Since chemical modifications in molecules can enhance their antifungal properties, this study aimed to evaluate the anti-<i>Sporothrix</i> activity of two analogs of (PhSe)₂—p-methoxyl-diphenyl diselenide (BMD) and bis-(3-trifluoromethylphenyl) diselenide (CF3)—both alone and in combination with itraconazole (ITZ). A total of 25 <i>Sporothrix</i> spp. isolates (<i>S. brasiliensis</i> <i>n</i> = 20; <i>S. schenckii</i> <i>n</i> = 4 and <i>S. globosa</i> <i>n</i> = 1) were included. The microdilution and checkerboard assays were used to assess its antifungal activity alone and in combination, respectively. BMD inhibited all isolates, with a total minimum inhibitory concentration ranging from 2 to 16&#xa0;µg/mL. In contrast, CF3 exhibited only a partial minimum inhibitory concentration activity in 92% of isolates at concentrations ranging from 2 to 16&#xa0;µg/mL. When combined with ITZ, both compounds predominantly exhibited a synergistic effect (100% for BMD and 73% for CF3). Our study presents pioneering data on two organoselenium compounds with significant <i>in vitro</i> activity against the main pathogenic <i>Sporothrix</i> species, both alone and in combination with ITZ. Further studies are needed to determine whether these <i>in vitro</i> findings translate into <i>in vivo</i> efficacy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chemical modifications of diphenyl diselenide enhance its anti-Sporothrix spp. activity and exhibit synergism with itraconazole

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月8日

查看全文
  • Jéssica Estefania Dávila Hidalgo,
  • Melissa Orzechowski Xavier,
  • Mariana Rodrigues Trápaga,
  • Beatriz Cardoso,
  • Mônica Campos dos Santos,
  • Diulien Canary,
  • Gilson Zeni,
  • Cristina Wayne Nogueira,
  • Rodrigo Almeida-Paes,
  • Rosely Maria Zancopé-Oliveira,
  • Vanice Rodrigues Poester

摘要

Sporotrichosis is a globally distributed subcutaneous mycosis caused by fungi belonging to the Sporothrix genus. The limitations of current treatment options for sporotrichosis have driven an urgent search for new antifungal drugs. Diphenyl diselenide (PhSe)₂, a stable organoselenium, has promising activity against Sporothrix spp. Since chemical modifications in molecules can enhance their antifungal properties, this study aimed to evaluate the anti-Sporothrix activity of two analogs of (PhSe)₂—p-methoxyl-diphenyl diselenide (BMD) and bis-(3-trifluoromethylphenyl) diselenide (CF3)—both alone and in combination with itraconazole (ITZ). A total of 25 Sporothrix spp. isolates (S. brasiliensis n = 20; S. schenckii n = 4 and S. globosa n = 1) were included. The microdilution and checkerboard assays were used to assess its antifungal activity alone and in combination, respectively. BMD inhibited all isolates, with a total minimum inhibitory concentration ranging from 2 to 16 µg/mL. In contrast, CF3 exhibited only a partial minimum inhibitory concentration activity in 92% of isolates at concentrations ranging from 2 to 16 µg/mL. When combined with ITZ, both compounds predominantly exhibited a synergistic effect (100% for BMD and 73% for CF3). Our study presents pioneering data on two organoselenium compounds with significant in vitro activity against the main pathogenic Sporothrix species, both alone and in combination with ITZ. Further studies are needed to determine whether these in vitro findings translate into in vivo efficacy.